Average Co-Inventor Count = 10.07
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (16 from 1,323 patents)
2. Other (8 from 832,912 patents)
3. Pharmacia Corporation (1 from 220 patents)
4. G.d. Searle LLC (1 from 33 patents)
26 patents:
1. 7091319 - IL-3 variant hematopoiesis fusion protein
2. 6479261 - Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
3. 6458931 - Interleukin-3 (IL-3) multiple mutation polypeptides
4. 6440407 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides
5. 6436387 - Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
6. 6413509 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
7. 6403076 - Compositions for increasing hematopoiesis with interleukin-3 mutants
8. 6379662 - Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
9. 6361976 - Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
10. 6361977 - Methods of using multivariant IL-3 hematopoiesis fusion protein
11. 6153183 - Co-administration of interleukin-3 mutant polypeptides with CSF's or
12. 6132991 - Human interleukin-3 (IL-3) variant fusion proteins
13. 6093395 - Co-administration of interleukin-3 mutant polypeptides with CSF's for
14. 6074639 - Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3)
15. 6060047 - Co-administration of interleukin-3 mutant polypeptides with CSF's for